the ability of Regenerons collaborators, licensees, suppliers, or other third parties (as applicable) to perform manufacturing, filling, finishing, packaging, labeling, distribution, and other steps related to Regenerons Products and Regenerons Product Candidates
Previously, 2.4mg Semaglutide injection lost 15.8% of weight at 68 weeks (STEP-8 trial)
Its designed to be administered once a week in conjunction with diet and exercise, and has a max dosage of 2 milligrams (mg)
Comparative tolerability of sulphonylureas in diabetes mellitus
Cardiac research has shown it may help reduce scar tissue after heart injury
Common adverse reactions include nausea, vomiting, diarrhea, abdominal pain and constipation